Archive: Diagnosing hematologic neoplasms today and tomorrow

Diagnosing hematologic neoplasms is based on the integrated application of a combination of phenotypic and genetic methods aiming at specifying patient-specific disease entity allowing for individualized therapy. Optimization and automation of various laboratory processes allows for comprehensive large scale application of such diagnostics which is anticipated to evolve into even more complexity. Prof. Dr. Wolfgang Kern, M.D. Managing Director, Head of Immunophenotyping MLL Munich Leukemia Laboratory, Munich, Germany International Clinical Cytometry Society (ICCS) Vice President 10/09/24 The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.